Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Mechanisms of Ageing and Development|January 26, 2011
Age trajectories of physiological indices in relation to healthy life courseKonstantin G Arbeev, Svetlana V Ukraintseva, Igor Akushevich, et al.
Epidemiology (Cambridge, Mass.)|April 1, 2026
Validity of military service as reported on U.S. death certificatesCandice Y Johnson, Lucy Akushevich, Heather R Batchelder, et al.
Current Gerontology and Geriatrics Research|October 19, 2010
Dynamic determinants of longevity and exceptional healthAnatoli I Yashin, Konstantin G Arbeev, Igor Akushevich, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.
BMC Cancer|September 23, 2014
A multi-center population-based case-control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES)Joellen M Schildkraut, Anthony J Alberg, Elisa V Bandera, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 22, 2016
Effectiveness and Safety of Sofosbuvir-Based Regimens for Chronic HCV Genotype 3 Infection: Results of the HCV-TARGET StudyJordan J Feld, Raoel Maan, Stefan Zeuzem, et al.
Hepatology Communications|October 9, 2019
Treatment Status of Hepatocellular Carcinoma Does Not Influence Rates of Sustained Virologic Response: An HCV-TARGET AnalysisKavita Radhakrishnan, Adrian M Di Bisceglie, K Rajender Reddy, et al.
Journal of Women'S Health (2002)|February 18, 2016
The Association Between Body Mass Index and Presenting Symptoms in African American Women with Ovarian CancerChioma O Erondu, Anthony J Alberg, Elisa V Bandera, et al.
Journal of Hepatology|April 4, 2020
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohortElizabeth C Verna, Giuseppe Morelli, Norah A Terrault, et al.
Gut|July 16, 2016
Effectiveness and safety of sofosbuvir plus ribavirin for the treatment of HCV genotype 2 infection: results of the real-world, clinical practice HCV-TARGET studyTania M Welzel, David R Nelson, Giuseppe Morelli, et al.
Pageof 4